With a market capitalisation of ₹8,369 crores, Relaxo operates in the highly competitive footwear segment where it competes with peers like Bata India, Metro Brands, and Campus Activewear. The March quarter's performance represents a cyclical uptick, but the company continues to grapple with multi-year challenges including margin compression, declining return ratios, and persistent underperformance against market benchmarks. The stock's current valuation at 45 times trailing earnings appears stretched given the underlying operational headwinds and weak growth trajectory.
Financial Performance: Sequential Recovery Masks Annual Weakness
Relaxo Footwears' March 2026 quarter demonstrated strong sequential momentum, with net sales climbing 12.44% quarter-on-quarter to ₹751.10 crores—the highest quarterly revenue in the trailing twelve-month period. However, the year-on-year growth of 8.05% reveals the challenges the company faced throughout FY2026, with full-year revenues declining 4.3% to ₹2,789 crores compared to FY2025.
| Quarter | Revenue (₹ Cr) | QoQ Growth | Net Profit (₹ Cr) | QoQ Growth | Operating Margin |
|---|---|---|---|---|---|
| Mar'26 | 751.10 | +12.44% | 67.67 | +154.96% | 16.51% |
| Dec'25 | 668.03 | +6.28% | 26.54 | -26.60% | 10.39% |
| Sep'25 | 628.54 | -3.96% | 36.16 | -26.05% | 12.91% |
| Jun'25 | 654.49 | -5.85% | 48.90 | -13.02% | 15.20% |
| Mar'25 | 695.15 | +4.24% | 56.22 | +70.28% | 16.12% |
| Dec'24 | 666.90 | -1.84% | 33.01 | -10.12% | 12.50% |
| Sep'24 | 679.37 | — | 36.73 | — | 12.90% |
The March quarter's operating profit margin of 16.51% represents a significant improvement from the 10.39% recorded in December 2025, driven primarily by better operating leverage as revenues scaled up. Net profit margin expanded to 9.01% from 3.97% in the previous quarter. However, the annual picture remains concerning—FY2026 operating margins at 13.8% remain substantially below the 21.1% achieved in FY2021, highlighting persistent cost pressures and pricing challenges.
Employee costs declined sharply to ₹96.01 crores in Q4 FY26 from ₹110.24 crores in the previous quarter, contributing to margin expansion. The company maintained disciplined tax planning with an effective rate of 25.46%, consistent with previous quarters. Other income remained stable at ₹11.66 crores, contributing 1.55% to total revenues.
Operational Challenges: Weak Return Ratios Signal Efficiency Concerns
Despite the sequential improvement in profitability, Relaxo's operational efficiency metrics remain deeply concerning. The company's return on equity (ROE) stands at a weak 7.96% for the latest period, substantially below the peer group average and indicative of poor capital allocation. This represents a significant deterioration from the 11.32% average ROE over recent years and highlights the company's struggle to generate adequate returns for shareholders.
Critical Concern: Deteriorating Capital Efficiency
Relaxo's ROE of 7.96% ranks amongst the lowest in its peer group, with only Sreeleathers (5.76%) performing worse. Competitors like Redtape (24.09%), Metro Brands (21.66%), and Campus Activewear (19.33%) demonstrate significantly superior capital efficiency. The company's return on capital employed (ROCE) at 10.43% has also declined from the five-year average of 15.65%, indicating persistent challenges in generating adequate returns from deployed capital.
The company's balance sheet reveals a debt-free structure with net cash position, which should theoretically support higher returns. However, shareholder funds of ₹2,098.07 crores as of March 2025 are generating insufficient profits, with the trailing twelve-month profit after tax of ₹170 crores translating to an ROE of approximately 8.1%. This suggests either excess capital sitting idle or operational inefficiencies constraining profitability.
Fixed assets stood at ₹972.74 crores as of March 2025, down from ₹1,028.25 crores a year earlier, indicating limited capacity expansion. Current assets of ₹1,234.60 crores remained largely stable, whilst current liabilities declined to ₹450.82 crores, improving working capital management. The company's sales to capital employed ratio of 1.34 times suggests moderate asset utilisation, though this has remained relatively stagnant over recent years.
Industry Context: Navigating a Challenging Footwear Landscape
The Indian footwear industry has witnessed significant headwinds over the past two years, with changing consumer preferences, increased competition from unorganised players, and raw material inflation squeezing margins across the sector. Relaxo's underperformance of 6.28% against the footwear sector's one-year decline of 25.97% provides some relative comfort, but the absolute returns remain deeply negative.
Sector Dynamics: Margin Pressure Across the Board
The footwear sector has experienced widespread margin compression, with most players struggling to pass on input cost increases to consumers. Relaxo's operating margin decline from 21.1% in FY2021 to 13.8% in FY2026 mirrors industry-wide trends. However, better-positioned peers like Metro Brands and Campus Activewear have managed to maintain superior profitability through brand premiumisation and operational efficiencies—areas where Relaxo has lagged.
The company's five-year sales growth of 4.22% annually appears modest but reasonable given the sector context. More concerning is the five-year EBIT decline of 8.46% annually, indicating that whatever revenue growth was achieved came at the cost of profitability. This suggests pricing power challenges and inability to offset cost inflation through operational improvements.
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 2,702* | 2,789 | 2,914 | 2,782 | 2,653 | 2,359 |
| Operating Margin | 14.6%* | 13.8% | 14.0% | 12.1% | 15.7% | 21.1% |
| PAT (₹ Cr) | 179* | 170 | 200 | 154 | 232 | 291 |
| PAT Margin | 6.6%* | 6.1% | 6.9% | 5.5% | 8.7% | 12.3% |
*FY2026 figures based on trailing twelve months from quarterly data
Peer Comparison: Valuation Discount Reflects Operational Underperformance
Relaxo's valuation metrics reveal a meaningful discount to most peers, which appears justified given its inferior operational performance. Trading at 44.76 times trailing earnings, the company commands a lower multiple than Metro Brands (69.69x), Bata India (53.63x), and Campus Activewear (51.68x), though it trades at a premium to Sreeleathers (18.42x) and Redtape (32.50x).
| Company | P/E (TTM) | P/BV | ROE % | Div Yield % | Debt/Equity |
|---|---|---|---|---|---|
| Relaxo Footwears | 44.76 | 3.56 | 11.32 | 0.99 | -0.01 |
| Metro Brands | 69.69 | 14.38 | 21.66 | 0.52 | 0.44 |
| Bata India | 53.63 | 5.84 | 15.43 | 1.30 | 0.53 |
| Campus Activewear | 51.68 | 9.77 | 19.33 | 0.12 | 0.47 |
| Redtape | 32.50 | 7.65 | 24.09 | 0.17 | 0.70 |
| Sreeleathers | 18.42 | 0.93 | 5.76 | 0.52 | -0.02 |
The price-to-book ratio of 3.56 times appears reasonable on the surface, but when contextualised against the weak 7.96% ROE, it suggests the market is pricing in expectations of a turnaround that has yet to materialise. Peers generating ROEs above 15% justifiably command premium valuations—Metro Brands' 14.38x P/BV multiple is supported by its 21.66% ROE, whilst Relaxo's lower multiple reflects its inferior returns profile.
Relaxo's dividend yield of 0.99% provides some income support, with the company maintaining a 37.25% payout ratio despite earnings challenges. However, this yield remains below Bata India's 1.30% and fails to compensate for the capital erosion experienced by long-term shareholders. The company's debt-free status represents a structural advantage, providing financial flexibility that leveraged peers lack, but this hasn't translated into superior operational performance.
Valuation Analysis: Premium Multiples Unjustified by Fundamentals
At the current price of ₹350.95, Relaxo Footwears trades at a P/E ratio of 45 times trailing twelve-month earnings, representing a premium to the broader market despite underwhelming fundamentals. The company's EV/EBITDA multiple of 20.68 times appears particularly stretched given the margin compression trajectory and negative earnings growth over the past five years.
The valuation grade of "Very Expensive" assigned by market analysts reflects the disconnect between current multiples and underlying business quality. Historical context reveals the stock has oscillated between "Expensive" and "Very Expensive" categories since February 2023, with the market consistently pricing in optimism that operational performance has failed to deliver. The 52-week range of ₹236.55 to ₹531.45 demonstrates significant volatility, with the current price sitting 33.96% below the peak.
A fair value analysis based on peer multiples and return profiles suggests the stock should trade closer to 30-35 times earnings given its operational challenges, implying a fair value range of ₹255-295 per share—representing 15-27% downside from current levels. The market appears to be pricing in a sharp recovery in margins and growth that the company's track record doesn't support.
Shareholding Pattern: Institutional Caution Evident
The shareholding pattern reveals stable promoter holding at 71.27% across recent quarters, providing governance comfort but also limiting free float. More concerning is the gradual reduction in mutual fund holdings, which declined from 10.52% in March 2025 to 9.62% in March 2026—a 90 basis point reduction that signals waning institutional confidence.
| Holder Type | Mar'26 | Dec'25 | Sep'25 | Jun'25 | Mar'25 | QoQ Change |
|---|---|---|---|---|---|---|
| Promoters | 71.27% | 71.27% | 71.27% | 71.27% | 71.27% | 0.00% |
| Mutual Funds | 9.62% | 9.77% | 9.80% | 9.92% | 10.52% | -0.15% |
| FIIs | 3.04% | 3.01% | 3.03% | 2.86% | 3.07% | +0.03% |
| Insurance | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Other DIIs | 0.12% | 0.11% | 0.08% | 0.03% | 0.03% | +0.01% |
| Public | 15.95% | 15.85% | 15.82% | 15.93% | 15.12% | +0.10% |
Foreign institutional investor (FII) holdings have remained largely stable around 3%, indicating neither strong conviction nor complete abandonment. The absence of insurance company holdings is notable, as these long-term investors typically favour quality businesses with stable cash flows. Total institutional holdings of just 12.78% rank amongst the lowest in the peer group, suggesting limited institutional appetite for the stock at current valuations.
The promoter group, led by Ramesh Kumar Dua (23.43%) and Mukand Lal Dua (20.57%), maintains strong control with zero pledging—a positive indicator of financial stability and confidence. However, the lack of meaningful institutional participation limits liquidity and suggests sophisticated investors remain unconvinced about the investment case.
Stock Performance: Severe Wealth Destruction Over Multiple Timeframes
Relaxo's stock performance represents one of the more dramatic wealth destruction stories in the Indian footwear sector. The shares have declined 59.86% over three years, 63.56% over four years, and a staggering 68.64% over five years—massively underperforming the Sensex, which gained 20.20% and 46.90% over the same three-year and five-year periods respectively.
| Period | Stock Return | Sensex Return | Alpha |
|---|---|---|---|
| 1 Day | +16.27% | -0.43% | +16.70% |
| 1 Week | +19.17% | +0.17% | +19.00% |
| 1 Month | +15.33% | -2.52% | +17.85% |
| 3 Months | +0.89% | -7.07% | +7.96% |
| 6 Months | -14.33% | -11.86% | -2.47% |
| 1 Year | -19.69% | -7.46% | -12.23% |
| 2 Years | -56.63% | +1.39% | -58.02% |
| 3 Years | -59.86% | +20.20% | -80.06% |
| 5 Years | -68.64% | +46.90% | -115.54% |
The recent one-day surge of 16.27% following the quarterly results represents a relief rally rather than a trend reversal. Short-term momentum indicators show positive movement over one week (+19.17%) and one month (+15.33%), but these gains merely represent a partial recovery from deeply oversold levels. The stock remains 33.96% below its 52-week high of ₹531.45.
Risk-adjusted returns paint an even grimmer picture, with the stock generating a negative Sharpe ratio and classified as "High Risk Low Return"—the worst possible combination for investors. Volatility of 35.01% significantly exceeds the Sensex's 12.97%, whilst the beta of 1.24 indicates above-average sensitivity to market movements. The stock's technical trend remains "Mildly Bearish," with resistance at the 20-day moving average of ₹297.26 and major resistance at the 200-day moving average of ₹384.80.
Investment Thesis: Quality Concerns Override Cyclical Recovery
The investment case for Relaxo Footwears rests on several parameters that collectively paint a cautious picture. The company's quality grade of "Average" reflects long-term financial performance that has deteriorated from "Good" prior to May 2023. Whilst the debt-free balance sheet and absence of promoter pledging provide structural comfort, these positives are overwhelmed by weak return ratios and declining operational metrics.
The financial trend turned "Positive" in March 2026 based on the strong quarterly performance, with net sales, operating profit, and PAT all reaching quarterly highs. However, this represents a single quarter of improvement against a backdrop of multi-year decline. The technical trend remains "Mildly Bearish," with the stock trading below all major moving averages except the very short-term ones.
The company's overall advisory score of 41 out of 100 places it firmly in "SELL" territory, with the rating unchanged since October 2025. Key concerns limiting the score include persistent underperformance against benchmarks, negative five-year EBIT growth of 8.46%, and bearish technical positioning. The stock's classification as "High Risk Low Return" over the past year validates the cautious stance.
Key Strengths & Risk Factors
KEY STRENGTHS
- Completely debt-free balance sheet with net cash position providing financial flexibility
- Strong brand portfolio including Sparx, Flite, Bahamas with established market presence
- Zero promoter pledging indicating financial stability and promoter confidence
- Stable promoter holding at 71.27% ensuring governance continuity
- Sequential improvement in Q4 FY26 with margins expanding to 16.51%
- Consistent dividend payer with 37.25% payout ratio despite earnings pressure
- Manufacturing capabilities across multiple product categories and price points
KEY CONCERNS
- Extremely weak ROE of 7.96%, lowest amongst major peers, indicating poor capital efficiency
- Five-year EBIT decline of 8.46% annually reflects structural profitability challenges
- Operating margins compressed from 21.1% (FY21) to 13.8% (FY26), losing 730 basis points
- Severe stock underperformance: -59.86% over three years vs Sensex +20.20%
- Declining institutional confidence with mutual fund holdings falling 90 bps to 9.62%
- Valuation grade "Very Expensive" at 45x P/E despite weak fundamentals
- High volatility (35.01%) with negative risk-adjusted returns classified as "High Risk Low Return"
Outlook: What Lies Ahead for Relaxo
The path forward for Relaxo Footwears requires sustained operational improvement across multiple dimensions. The March quarter's strong performance provides a base, but investors need evidence of sustained margin expansion, revenue growth acceleration, and improvement in return ratios before revising their cautious stance.
POSITIVE CATALYSTS TO WATCH
- Sustained margin improvement above 16% for at least three consecutive quarters
- Revenue growth acceleration to double digits with market share gains
- ROE improvement trajectory towards 12-15% through better capital deployment
- Successful brand premiumisation initiatives driving pricing power
- Institutional buying resumption with mutual fund holdings stabilising above 10%
RED FLAGS TO MONITOR
- Margin relapse below 14% indicating Q4 FY26 was an aberration
- Revenue growth remaining in low single digits unable to offset inflation
- Further decline in institutional holdings signalling smart money exit
- ROE remaining below 8% for multiple quarters cementing low-return profile
- Stock breaking below ₹236 support level triggering fresh technical weakness
Management commentary on capacity utilisation, brand-wise performance, and channel expansion will be crucial in assessing whether the March quarter represents a sustainable turnaround or merely a cyclical uptick. The company's ability to improve return ratios whilst maintaining its debt-free status will determine whether the current valuation premium can be justified.
The Verdict: Operational Recovery Required Before Investment Merit Emerges
Score: 41/100
For Fresh Investors: Avoid initiating positions at current levels. The combination of stretched valuations (45x P/E), weak return ratios (7.96% ROE), and declining five-year EBIT growth presents an unfavourable risk-reward profile. Wait for sustained operational improvement across at least three quarters and valuation correction towards ₹255-295 before considering entry.
For Existing Holders: Consider using the recent 16% rally as an exit opportunity. The three-year wealth destruction of 59.86% and persistent underperformance against benchmarks suggest structural challenges that a single strong quarter cannot resolve. The stock's "Very Expensive" valuation grade provides limited downside protection if operational momentum falters.
Fair Value Estimate: ₹275 (21.6% downside from current levels) based on 35x P/E multiple applied to normalised earnings, reflecting quality concerns and growth challenges.
Note: ROCE = (EBIT - Other income)/(Capital Employed - Cash - Current Investments)
⚠️ Investment Disclaimer
This article is for educational and informational purposes only and should not be construed as financial advice. Investors should conduct their own due diligence, consider their risk tolerance and investment objectives, and consult with a qualified financial advisor before making any investment decisions.
